Quarterly and annual results disclosed under 8-K Item 2.02.
Coherus Oncology, Inc. reported the three months ended December 31, 2025 results: revenue $12.7 million.
“Net revenue from continuing operations was $12.7 million and $7.7 million during the three months ended December 31, 2025 and 2024, respectively, and $42.2 million and $26.4 million during the years ended December 31, 2025 and 2024, respectively.”
Sphere 3D Corp. reported fiscal year ended December 31, 2025 results: revenue $11.2 million.
“Company mined 111.6 Bitcoin. As of December 31, 2025, the Company had a self-mined balance of 37.3 Bitcoin. FISCAL YEAR 2025 FINANCIAL RESULTS • The Company generated revenue of $11.2 million in fiscal year 2025 compared to $16.6 million in 2024, primarily due to the April 2024 halving event, and the process of removing our older mining equipment and replacing it with”
Corbus Pharmaceuticals Holdings, Inc. reported fourth quarter and year ended December 31, 2025 results: net income net loss of approximately $20.6 million, or a net loss per basic and diluted share of $1.25, EPS net loss per basic and diluted share of $1.25.
“The Company reported a net loss of approximately $20.6 million, or a net loss per basic and diluted share of $1.25, for the three months ended December 31, 2025, compared to a net loss of $9.5 million, or a net loss per basic and diluted share of $0.78, for the three months ended December 31, 2024.”
RideNow Group, Inc. reported financial results for the fourth quarter and year ended December 31, 2025.
“On March 9, 2026, the Company issued a press release announcing its results for the fourth quarter and year ended December 31, 2025.”
Heritage Insurance Holdings, Inc. reported fiscal quarter and full year ended December 31, 2025 results: revenue Total revenue $215,317 thousand for the three months ended December 31, 2025; Total revenue $847,330 thousand for the ye, net income Net income $66,675 thousand for the three months ended December 31, 2025; Net income $195,594 thousand for the year ende, EPS Earnings Per Diluted Share $2.15 for the three months ended December 31, 2025; Earnings Per Diluted Share $6.32 for the.
“Heritage Insurance Holdings, Inc. (the "Company") issued a press release announcing financial results for its fiscal quarter and full year ended December 31, 2025.”
Yext, Inc. reported the fiscal year ended January 31, 2026 results: revenue $446.6 million, EPS $0.31.
“Yext Announces Fourth Quarter and Fiscal Year 2026 Results – Q4 Revenue of $112.0 million and FY26 Revenue of $446.6 million – Q4 Net Income Per Share, basic, of $0.03 or non-GAAP Net Income Per Share of $0.15 – FY26 Net Income Per Share, basic, of $0.31 or non-GAAP Net Income Per Share of $0.56”
Yext, Inc. reported the three months ended January 31, 2026 results: revenue $112.0 million, EPS $0.03.
“Yext Announces Fourth Quarter and Fiscal Year 2026 Results – Q4 Revenue of $112.0 million and FY26 Revenue of $446.6 million – Q4 Net Income Per Share, basic, of $0.03 or non-GAAP Net Income Per Share of $0.15 – FY26 Net Income Per Share, basic, of $0.31 or non-GAAP Net Income Per Share of $0.56”
Voyager Therapeutics, Inc. reported the year ended December 31, 2025 results: revenue $40.4 million, net income $119.7 million.
“● Collaboration Revenues: Collaboration revenue was $15.3 million for the three months ended December 31, 2025, compared to $6.3 million for the same period in 2024 , and $40.4 million for the year ended December 31, 2025, compared to $80.0 million for the same period in 2024. The increase for the three months ended December 31, 2025, was primarily due to”
Voyager Therapeutics, Inc. reported the three months ended December 31, 2025 results: revenue $15.3 million, net income $27.4 million.
“intends to initiate a clinical trial with NBIB-‘223 for FA, pending successful FDA IND clearance Financial Results ● Collaboration Revenues: Collaboration revenue was $15.3 million for the three months ended December 31, 2025, compared to $6.3 million for the same period in 2024 , and $40.4 million for the year ended December 31, 2025, compared to $80.0”
Hewlett Packard Enterprise Co reported first quarter ended January 31, 2026 results: revenue $9.3 billion, EPS $0.31. Guidance raised.
“and underscore our confidence that we will drive profitable, sustainable growth while transforming the way we operate.” First Quarter Fiscal 2026 Financial Results • Revenue : $9.3 billion, up 18% from the prior-year period • Gross margins : ◦ GAAP of 35.9%, up 670 basis points from the prior-year period and up 240 basis points sequentially ◦ Non-GAAP (1) of 36.6%,”
Ondas Inc. reported the full year 2025 results: revenue between $49.7 and $50.7 million, net income between $(53.3) and $(52.8) million. Guidance reaffirmed.
“For the full year 2025, we expect to report revenues between $49.7 and $50.7 million, which is above our prior guidance of $47.6 to $49.6 million. We expect net loss between $(53.3) and $(52.8) million and adjusted EBITDA between $(32.9) and $(32.4) million.”
Ondas Inc. reported the fourth quarter of 2025 results: revenue between $29.1 and $30.1 million, net income between $(20.9) and $(20.4) million.
“For the fourth quarter of 2025, we expect to report revenues between $29.1 and $30.1 million, which is above our prior guidance of $27 to $29 million. We expect net loss between $(20.9) and $(20.4) million, and adjusted EBITDA between $(11.4) and $(10.9) million.”
Editas Medicine, Inc. reported financial results for the fourth quarter and full year 2025.
“On March 9, 2026 , Editas Medicine, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025 and other business highlights.”
ARS Pharmaceuticals, Inc. reported financial results for quarter and year ended December 31, 2025.
“On March 9, 2026, ARS Pharmaceuticals, Inc. (the “Company”) announced its financial results for the quarter and year ended December 31, 2025 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference.”
SPRUCE BIOSCIENCES, INC. reported the year ended December 31, 2025 results: net income $3.
“Net loss for the year ended December 31, 2025 was $3”
Dianthus Therapeutics, Inc. /DE/ reported the fourth quarter and full year ending December 31, 2025 results: net income $162.3 million or $4.20 per share, EPS $4.20 per share.
“On March 9, 2026, Dianthus Therapeutics, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter and full year ended December 31, 2025.”
Repay Holdings Corp reported financial results for quarter and year ended December 31, 2025.
“On March 9, 2026, Repay Holdings Corporation (the “Company”) issued a press release announcing the results of the Company’s operations for the quarter and year ended December 31, 2025.”
Boundless Bio, Inc. reported fourth quarter and full year ended December 31, 2025 results: net income Net loss totaled $12.9 million for the fourth quarter of 2025 and $58.2 million for the full year 2025.
“Net loss totaled $12.9 million for the fourth quarter of 2025 and $58.2 million for the full year 2025, compared to $16.4 million and $65.4 million for the same periods of 2024.”
BETA Technologies, Inc. reported the quarter and year ended December 31, 2025 results: revenue $35.6 million, net income ($745.9) million.
“in communities nationwide while expanding the use of BETA's charging network through the eVTOL Integration Pilot Program ("eIPP"). 1 Financial Highlights • FY25 Revenues of $35.6 million • FY25 Net loss of ($745.9) million • FY25 Adjusted EBITDA of ($304.1) million Fourth Quarter and Full Year 2025 Key Financial Metrics (in thousands) Three Months Ended December”
Voyager Technologies, Inc./DE reported financial results for the quarterly period ended December 31, 2025.
“On March 9, 2026 , Voyager Technologies, Inc. (the “Company”) issued a press release announcing its financial results for the quarterly period ended December 31, 2025.”
Design Therapeutics, Inc. reported financial results for the three and twelve months ended December 31, 2025.
“On March 9, 2026, Design Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the three and twelve months ended December 31, 2025.”
Vicarious Surgical Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income GAAP net loss in the fourth quarter of 2025 was $10.5 million, EPS GAAP net loss per share of $1.57.
“On March 9, 2026, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the fiscal year and fourth fiscal quarter ended December 31, 2025.”
Global Business Travel Group, Inc. updated its the quarter and year ended December 31, 2025 guidance (reaffirmed).
“On March 9, 2026, Global Business Travel Group, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter and year ended December 31, 2025.”
NET Power Inc. reported financial results for the quarter and year ended December 31, 2025.
“Net Power Inc., a Delaware corporation, issued a press release setting forth its financial results for the quarter and year ended December 31, 2025.”
Global Crossing Airlines Group Inc. reported financial results for fourth quarter and full year ended December 31, 2025.
“On March 4, 2026, Global Crossing Airlines Group Inc. (the “Company”) issued a press release (the “Press Release”) announcing its financial and operating results for the fourth quarter and full year ended December 31, 2025.”
Unusual Machines, Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $11.2 million, net income $19.2 million.
“Revenue for 2025 totaled approximately $11.2 million, representing 101% year-over-year growth, and fourth quarter revenue was approximately $4.9 million, representing 133% sequential quarterly growth.”
enGene Therapeutics Inc. reported first quarter ended January 31, 2026 results: net income net loss attributable to common shareholders was approximately $29.8 million, EPS $0.44 per share.
“enGene Reports First Quarter 2026 Financial Results and Provides Business Update”
Sharplink, Inc. reported financial results for full year ended December 31, 2025.
“On March 9, 2026, Sharplink, Inc.. (the "Company") issued a press release regarding its financial results for the year ended December 31, 2025.”
Septerna, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $24.1 million for the fourth quarter of 2025 and $46.0 million for the full year ended December 31, 2025, net income Net loss was $10.7 million for the fourth quarter of 2025 and $48.9 million for the full year ended December 31, 2025.
“On March 9, 2026, Septerna, Inc. (the “Company”) announced its financial results and business highlights for the fourth quarter and year ended December 31, 2025.”
KORN FERRY reported third quarter fiscal year 2026 results: revenue $717.4 million, net income $65.3 million, EPS $1.23.
“(214) 310-8407 Media: Dan Gugler, (310) 226-2645 Korn Ferry Announces Third Quarter Fiscal 2026 Results of Operations Highlights ▪ Korn Ferry reports Q3 FY'26 fee revenue of $717.4 million, an increase of 7% year-over-year with growth in all solutions. ▪ Net income attributable to Korn Ferry increased 12% year-over-year, with a margin of 9.1%. ▪ Adjusted EBITDA”
ACCO BRANDS Corp reported Full Year Results results: revenue $1.525 billion, net income $41.3 million, EPS $0.44 per share.
“Net sales were $1.525 billion, down 8.5 percent from $1.666 billion in 2024. Net sales declines reflect the impact of softer global demand and tariff-related disruptions. Operating income was $92.3 million, versus an operating loss of $37.0 million in 2024, primarily due to non-cash impairment charges of $165.2 million related to goodwill and intangible assets within the Americas segment in the prior year. Restructuring expense associated with our multi-year cost reduction program was $21.6 million, compared to $16.8 million in the prior year. Current year operating income benefited from a net gain on sale of assets of $6.8 million. Adjusted operating income was $153.3 million, down from $189.7 million in 2024. Adjusted operating income decline reflects lower sales volume and tariff-related impacts, which were partially offset by cost savings and lower incentive compensation expense. Net income was $41.3 million, or $0.44 per share, compared to a net loss of $101.6 million, or $(1.06)”
ACCO BRANDS Corp reported Fourth Quarter Results results: revenue $428.8 million, net income $21.3 million, EPS $0.23 per share.
“Net sales were $428.8 million, down 4.3 percent from $448.1 million in 2024. Favorable foreign exchange increased sales by $15.8 million, or 3.5 percent. Comparable sales decreased 7.8 percent. The decline in net sales reflects softer global demand for some of our core products, partially offset by growth in gaming accessories. Operating income was $40.0 million, versus $42.0 million in 2024. Restructuring expense was $8.4 million, compared to $10.7 million in the prior year. Adjusted operating income was $60.1 million, compared to $64.2 million in 2024. The decline in adjusted operating income reflects lower sales volume, reduced fixed-cost absorption, and unfavorable product mix, which were partially offset by cost savings and lower incentive compensation expense. Net income was $21.3 million, or $0.23 per share, compared with prior-year net income of $20.6 million, or $0.21 per share.”
NL INDUSTRIES INC reported the full year of 2025 results: net income a net loss attributable to NL stockholders of $37.8 million, EPS $.77 per share.
“For the full year of 2025, NL reported a net loss attributable to NL stockholders of $37.8 million, or $.77 per share, compared to net income attributable to NL stockholders of $67.2 million, or $1.38 per share for the full year of 2024.”
NL INDUSTRIES INC reported the fourth quarter of 2025 results: net income a net loss attributable to NL stockholders of $31.0 million, EPS $.63 per share.
“NL INDUSTRIES, INC. (NYSE: NL) today reported a net loss attributable to NL stockholders of $31.0 million, or $.63 per share, in the fourth quarter of 2025 compared to net income attributable to NL stockholders of $16.5 million, or $.34 per share, in the fourth quarter of 2024.”
CASEYS GENERAL STORES INC updated its fiscal 2026 guidance (raised).
“As a result of the strong financial performance year-to-date, fiscal 2026 EBITDA is expected to increase 18% to 20%. The Company now expects inside same-store sales to increase 3.5% to 4.5% and an inside margin of approximately 41.5% to 42.5%. Total operating expenses are now expected to increase approximately 10%. The tax rate is now expected to be 23.5% to 24.5% for the fiscal year. Net interest expense is expected to be approximately $100 million.”
CASEYS GENERAL STORES INC reported three months ended January 31, 2026 results: net income $130.1 million, EPS $3.49.
“Third Quarter Key Highlights • Diluted EPS of $3.49 up 49.8% from the same period a year ago. Net income was $130.1 million, up 49.3% from the prior year, and EBITDA 1 was $308.9 million, up 27.5%, from the same period a year ago.”
VAIL RESORTS INC reported fiscal 2026 results: net income $144 million to $190 million. Guidance lowered.
“The Company reduced its fiscal 2026 guidance and is now expecting net income attributable to Vail Resorts, Inc. of $144 million to $190 million and Resort Reported EBITDA of $745 million to $775 million.”
VAIL RESORTS INC reported the second quarter of fiscal 2026 ended January 31, 2026 results: net income $210.0 million.
“• Q2 fiscal 2026 net income attributable to Vail Resorts, Inc. was $210.0 million compared to $244.4 million in the prior year.”
SIGNET JEWELERS LTD reported Full Year Fiscal 2026 results: revenue Sales of approximately $6.8 billion..
“Preliminary Full Year Fiscal 2026 Range Highlights: • Sales of approximately $6.8 billion.”
SIGNET JEWELERS LTD reported Fourth Quarter Fiscal 2026 results: revenue Sales of $2.34 to $2.35 billion.
“Preliminary Fourth Quarter Fiscal 2026 Range Highlights: • Sales of $2.34 to $2.35 billion.”
FUELCELL ENERGY INC reported first quarter ended January 31, 2026 results: revenue $30.5 million, net income Net loss (26,051), EPS $(0.49).
“FuelCell Energy, Inc. (NASDAQ: FCEL) today reported financial results for its first quarter ended January 31, 2026. First Quarter Fiscal 2026 Highlights (All comparisons are year-over-year unless otherwise noted) ● Revenue of $30.5 million, compared to $19.0 million, an increase of approximately 61% ● Gross loss of $(5.9) million, compared to $(5.2) million, an increase of approximately 13% ● Loss from operations of $(26.3) million, compared with $(32.9) million, a decrease of approximately 20% ● Net loss per share attributable to common stockholders was $(0.49), compared with $(1.42)”
Creative Media & Community Trust Corp reported the three months ended December 31, 2025 results: net income $(17.7) million, EPS $(11.20) per diluted share.
“Net loss attributable to common stockholders of $(17.7) million, or $(11.20) per diluted share.”
3D SYSTEMS CORP reported the year ended December 31, 2025 results: revenue $386.9 million, net income $29.9 million, EPS $0.19 per diluted share.
“operating expense. Adjusting for Geomagic, Adjusted EBITDA improved by $17.1 million compared to the prior year period. Full Year 2025 Results 1 Total revenue decreased 12% to $386.9 million compared to the prior year period. Adjusting for Geomagic, total revenue declined 7% compared to the prior year period. Healthcare Solutions revenue decreased 5% to $179.6”
3D SYSTEMS CORP reported the fourth quarter ended December 31, 2025 results: revenue $106.3 million, net income $19.5 million, EPS $(0.15) per diluted share.
“March 9, 2026 - 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2025. • Fourth quarter revenue of $106.3 million grew 16% sequentially, above guidance of 8% to 10% growth, driven by a successful ramp-up of new printer system sales and higher materials consumption • For full year 2025, the”
LifeMD, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $46.9 million. Guidance initiated.
“Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.”
LifeMD, Inc. reported the year ended December 31, 2025 results: revenue $194.1 million. Guidance initiated.
“Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.”
Cohen & Co Inc. reported the fourth quarter and year ended December 31, 2025 results: revenue $102.7 Million in Fourth Quarter 2025 and $275.6 Million in Full Year 2025, net income Net Income Attributable to Cohen & Company Inc. of $8.1 Million, or $1.48 per Diluted Share, in Fourth Quarter 2025 and.
“On March 6, 2026, Cohen & Company Inc., a Maryland corporation (the “Company”), issued a press release announcing the Company’s financial results for the fourth quarter and year ended December 31, 2025.”
TIPTREE INC. reported financial results for the three months and year ended December 31, 2025.
“On March 6, 2026 Tiptree Inc. (the “Company” or “Tiptree”) issued a press release announcing its results of operations for the twelve months ended December 31, 2025.”
ADIAL PHARMACEUTICALS, INC. reported financial results for the 2025 fiscal year ended December 31, 2025.
“On March 6, 2026, Adial Pharmaceuticals, Inc., a Delaware corporation (the “Company”) issued a press release that included financial information for its fiscal year ended December 31, 2025.”
MAMMOTH ENERGY SERVICES, INC. reported Fourth quarter and full year ended December 31, 2025 results: revenue Q4 2025: $9.5 million; Full Year 2025: $44.3 million, net income Q4 2025 net loss: $12.3 million; Full Year 2025 net loss: $63.8 million, EPS Q4 2025 loss per share: $0.26; Full Year 2025 loss per share: $1.32.
“Total revenue from continuing operations was $9.5 million for the fourth quarter of 2025 compared to $10.0 million for the fourth quarter of 2024 and $10.9 million for the third quarter of 2025. Total revenue for the full year of 2025 was $44.3 million compared to $45.6 million in 2024. Net loss from continuing operations for the fourth quarter of 2025 was $12.3 million, or $0.26 per diluted share, compared to $9.6 million, or $0.20 per diluted share, for the fourth quarter of 2024 and $12.6 million, or $0.26 per diluted share, for the third quarter of 2025. Net loss for the full year of 2025 was $63.8 million, or $1.32 per diluted share, compared to net loss of $183.1 million, or $3.81 per diluted share for 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.